Combination Therapy of Personalized Peptide Vaccination and Low-Dose Estramustine Phosphate for Metastatic Hormone Refractory Prostate Cancer Patients: An Analysis of Prognostic Factors in the Treatment-Reference-Cited by-同舟云学术

Combination Therapy of Personalized Peptide Vaccination and Low-Dose Estramustine Phosphate for Metastatic Hormone Refractory Prostate Cancer Patients: An Analysis of Prognostic Factors in the Treatment

Published:2006-07-01 Issue:7 Volume:16 Page:341-349
ISSN:0965-0407
Container-title:Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
language:en
Short-container-title:oncol res

Author:

Noguchi Masanori¹,Mine Takashi²,Yamada Akira³,Obata Yayoi²,Yoshida Kazumi²,Mizoguchi Junko²,Harada Mamoru²,Suekane Shigetaka⁴,Itoh Kyogo³,Matsuoka Kei⁴

Affiliation:

1. Department of Urology, Kurume University School of Medicine, Kurume University, Kurume, Japan, Research Center of Innovative Cancer Therapy of The 21st Century Center of Excellence (COE) Program for Medical Science, Kurume University, Kurume, Japan

2. Department of Immunology, Kurume University School of Medicine, Kurume University, Kurume, Japan

3. Department of Immunology, Kurume University School of Medicine, Kurume University, Kurume, Japan, Research Center of Innovative Cancer Therapy of The 21st Century Center of Excellence (COE) Program for Medical Science, Kurume University, Kurume, Japan

4. Department of Urology, Kurume University School of Medicine, Kurume University, Kurume, Japan

Publisher

Cognizant, LLC

Subject

Cancer Research,Oncology,General Medicine

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients;Cancer Immunology, Immunotherapy;2020-05-11

2. CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine‐treated ovarian cancer patients;Cancer Science;2020-03-06

3. Personalized neoantigen vaccines: A new approach to cancer immunotherapy;Bioorganic & Medicinal Chemistry;2018-06

4. Personalized peptide vaccines for cancer therapy: current progress and state of the art;Expert Review of Precision Medicine and Drug Development;2017-11-02

5. Chemoprevention by Fisetin;Cancer and Chemoprevention: An Overview;2017